Correlation Between Visa and THC Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Visa and THC Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and THC Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and THC Therapeutics, you can compare the effects of market volatilities on Visa and THC Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of THC Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and THC Therapeutics.

Diversification Opportunities for Visa and THC Therapeutics

-0.78
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Visa and THC is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and THC Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on THC Therapeutics and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with THC Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of THC Therapeutics has no effect on the direction of Visa i.e., Visa and THC Therapeutics go up and down completely randomly.

Pair Corralation between Visa and THC Therapeutics

Taking into account the 90-day investment horizon Visa is expected to generate 19.89 times less return on investment than THC Therapeutics. But when comparing it to its historical volatility, Visa Class A is 26.35 times less risky than THC Therapeutics. It trades about 0.12 of its potential returns per unit of risk. THC Therapeutics is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  0.07  in THC Therapeutics on December 25, 2024 and sell it today you would lose (0.04) from holding THC Therapeutics or give up 57.14% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy96.77%
ValuesDaily Returns

Visa Class A  vs.  THC Therapeutics

 Performance 
       Timeline  
Visa Class A 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Visa may actually be approaching a critical reversion point that can send shares even higher in April 2025.
THC Therapeutics 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in THC Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively abnormal fundamental indicators, THC Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Visa and THC Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Visa and THC Therapeutics

The main advantage of trading using opposite Visa and THC Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, THC Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in THC Therapeutics will offset losses from the drop in THC Therapeutics' long position.
The idea behind Visa Class A and THC Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios